Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

For decades, Grifols grew rich from an empire built on blood. Founded by a plucky scientist and his two sons in the years after the Spanish Civil War, the company made a series of breakthroughs that ...

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

(Reuters) -Spanish renewable energy company Solaria said on Monday it expected energy prices to recover over the year, which would help the firm reach its 2024 profitability target. Solaria shares ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

Activist short seller Nate Anderson is going out ‘on top’, according to one rival, as difficulties for short sellers mount in a relentless bull market.

After hours: February 3 at 5:37:30 p.m. EST ...

CMOPF Cosmo Pharmaceuticals N.V.

The Europe In Vitro Diagnostics (IVD) market plays a crucial role in the region’s healthcare landscape, encompassing a wide range of diagnostic tests and technologies used for disease detection, ...